A detailed history of Jfs Wealth Advisors, LLC transactions in Organon & Co. stock. As of the latest transaction made, Jfs Wealth Advisors, LLC holds 547 shares of OGN stock, worth $8,976. This represents 0.0% of its overall portfolio holdings.

Number of Shares
547
Previous 444 23.2%
Holding current value
$8,976
Previous $9,000 11.11%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

BUY
$18.65 - $23.03 $1,920 - $2,372
103 Added 23.2%
547 $10,000
Q2 2024

Jul 15, 2024

SELL
$17.45 - $21.96 $1,919 - $2,415
-110 Reduced 19.86%
444 $9,000
Q1 2024

Apr 30, 2024

BUY
$13.78 - $18.8 $124 - $169
9 Added 1.65%
554 $10,000
Q4 2023

Feb 07, 2024

SELL
$10.95 - $17.32 $1,653 - $2,615
-151 Reduced 21.7%
545 $7,000
Q3 2023

Nov 02, 2023

BUY
$16.59 - $23.77 $414 - $594
25 Added 3.73%
696 $12,000
Q2 2023

Aug 07, 2023

SELL
$19.27 - $24.63 $1,368 - $1,748
-71 Reduced 9.57%
671 $13,000
Q1 2023

Apr 19, 2023

SELL
$21.42 - $32.08 $364 - $545
-17 Reduced 2.24%
742 $17,000
Q4 2022

Feb 13, 2023

BUY
$23.31 - $28.61 $1,888 - $2,317
81 Added 11.95%
759 $21,000
Q3 2022

Oct 21, 2022

BUY
$23.4 - $34.25 $1,778 - $2,603
76 Added 12.62%
678 $16,000
Q2 2022

Aug 02, 2022

BUY
$31.66 - $38.9 $1,994 - $2,450
63 Added 11.69%
602 $20,000
Q1 2022

May 02, 2022

SELL
$30.45 - $39.36 $2,649 - $3,424
-87 Reduced 13.9%
539 $19,000
Q4 2021

Feb 03, 2022

BUY
$28.67 - $37.13 $1,748 - $2,264
61 Added 10.8%
626 $19,000
Q3 2021

Nov 09, 2021

SELL
$28.63 - $35.64 $4,552 - $5,666
-159 Reduced 21.96%
565 $19,000
Q2 2021

Aug 04, 2021

BUY
$28.45 - $38.0 $20,597 - $27,512
724 New
724 $22,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $4.17B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Jfs Wealth Advisors, LLC Portfolio

Follow Jfs Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jfs Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jfs Wealth Advisors, LLC with notifications on news.